The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Learn how to license this index| Component | Country | Weight |
|---|---|---|
| ELI LILLY & CO | US | 18.54% |
| JOHNSON & JOHNSON | US | 10.21% |
| NOVARTIS AG-SPONSORED ADR | CH | 7.65% |
| NOVO-NORDISK A/S-SPONS ADR | DK | 7.55% |
| MERCK & CO. INC. | US | 5.96% |
| PFIZER INC | US | 4.79% |
| MCKESSON CORP | US | 4.63% |
| ABBVIE INC | US | 4.56% |
| SANOFI-ADR | FR | 4.49% |
| ZOETIS INC | US | 4.42% |
Gain access to all index Data and Services. Receive update on market developments, index news and corporate announcements.
Sign up nowAlready have an account? Log in here
Country weightings are based on the weightings of all index components in a certain country.
| Country | Components | Weight |
|---|---|---|
| Switzerland | 1 | 7.65% |
| Denmark | 1 | 7.55% |
| United States | 12 | 62.04% |
| France | 1 | 4.49% |
| Japan | 1 | 2.95% |
| United Kingdom | 3 | 12.19% |
| Israel | 1 | 1.61% |
| Ireland | 2 | 0.69% |
| Netherlands | 1 | 0.68% |
| Canada | 1 | 0.15% |
| Total | 24 | 100.00% |
Sector weightings are based on the weightings of all index components in a certain sector.
| Sector | Components | Weight |
|---|---|---|
| Health Care | 23 | 96.39% |
| Consumer Staples | 1 | 3.61% |
| Total | 24 | 100.00% |
| Size | Market Cap | Components | Weight |
|---|---|---|---|
| Large-Cap | 3,154,340,526,000 USD | 20 | 99.18% |
| Mid-Cap | 14,100,965,700 USD | 4 | 0.82% |
| Small-Cap | - | - | - |
| Micro-Cap | - | - | - |
| Total | 3,168,441,491,700 USD | 24 | 100.00% |
A license agreement is required to use MarketVector indexes, index data or trademarks for various commercial purpose. These include research and analysis, as well as the creation, introduction, promotion, or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds, or OTC products connected to or derived from MarketVectorTM Indexes.
We can help you learn more about acquiring a suitable license for your needs.
